TY - JOUR
T1 - Local/Topical Antibiotics for Peri-Implantitis Treatment: A Systematic Review
AU - Passarelli, Pier Carmine
AU - Netti, Andrea
AU - Lopez, Michele Antonio
AU - Giaquinto, Eleonora Favetti
AU - De Rosa, Giuseppe
AU - Aureli, Gianmarco
AU - Bodnarenko, Alina
AU - Papi, Piero
AU - Starzyńska, Anna
AU - Pompa, Giorgio
AU - D'Addona, Antonio
PY - 2021
Y1 - 2021
N2 - Most studies indicate that the mechanical removal of the bacterial biofilm from the implant surface is the central goal of peri-implantitis therapy. However, controversial results in the treatment of peri-implantitis have led to the consideration of additional strategies that include surgical approaches and chemical adjuvants. Local/topical antibiotics, such as minocycline, azithromycin, tetracycline, amoxicillin, doxycycline, and metronidazole, may improve the efficacy of the definitive treatment of the disease, but the lack of conclusive findings prevents their use in clinical practice. This systematic review aimed to evaluate the effect of local/topical antibiotics for peri-implantitis treatment. Randomised controlled studies (RCT) on patients with peri-implantitis and comparing the efficacy of local/topical antibiotics vs. placebo or mechanical debridement were included. A systematic search strategy was carried out using three registered databases (PubMed, Web of Science, and Scopus). RoB2 was used to assess risk of bias. Five RCTs were identified (n = 250 patients and 333 implants). Contrast results emerged among the included studies, and a high heterogeneity level was observed. Risk of bias revealed some concerns for three studies out of five, while one study was judged at high risk. Only one study analysed the limitations of its findings. Overall, local antibiotic use can be considered a valid approach in the treatment of peri-implantitis. Therefore, future long-term clinical trials with standardised protocols and antibiotics with similar biological activity profiles should be tested to achieve a valid and definitive conclusion.
AB - Most studies indicate that the mechanical removal of the bacterial biofilm from the implant surface is the central goal of peri-implantitis therapy. However, controversial results in the treatment of peri-implantitis have led to the consideration of additional strategies that include surgical approaches and chemical adjuvants. Local/topical antibiotics, such as minocycline, azithromycin, tetracycline, amoxicillin, doxycycline, and metronidazole, may improve the efficacy of the definitive treatment of the disease, but the lack of conclusive findings prevents their use in clinical practice. This systematic review aimed to evaluate the effect of local/topical antibiotics for peri-implantitis treatment. Randomised controlled studies (RCT) on patients with peri-implantitis and comparing the efficacy of local/topical antibiotics vs. placebo or mechanical debridement were included. A systematic search strategy was carried out using three registered databases (PubMed, Web of Science, and Scopus). RoB2 was used to assess risk of bias. Five RCTs were identified (n = 250 patients and 333 implants). Contrast results emerged among the included studies, and a high heterogeneity level was observed. Risk of bias revealed some concerns for three studies out of five, while one study was judged at high risk. Only one study analysed the limitations of its findings. Overall, local antibiotic use can be considered a valid approach in the treatment of peri-implantitis. Therefore, future long-term clinical trials with standardised protocols and antibiotics with similar biological activity profiles should be tested to achieve a valid and definitive conclusion.
KW - chemical adjuvants
KW - clinical practice guidelines
KW - local antibiotics
KW - minocycline
KW - peri-implant mucositis
KW - peri-implantitis
KW - chemical adjuvants
KW - clinical practice guidelines
KW - local antibiotics
KW - minocycline
KW - peri-implant mucositis
KW - peri-implantitis
UR - http://hdl.handle.net/10807/232123
U2 - 10.3390/antibiotics10111298
DO - 10.3390/antibiotics10111298
M3 - Article
SN - 2079-6382
VL - 10
SP - 1298-N/A
JO - Antibiotics
JF - Antibiotics
ER -